These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7613832)

  • 1. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
    Allen FJ; Van Velden DJ; Heyns CF
    Br J Urol; 1995 Jun; 75(6):751-4. PubMed ID: 7613832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
    Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
    Quek ML; Daneshmand S; Rodrigo S; Cai J; Dorff TB; Groshen S; Skinner DG; Lieskovsky G; Pinski J
    Urology; 2006 Jun; 67(6):1247-52. PubMed ID: 16697447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer and neuroendocrine differentiation.
    Tan MO; Karaoğlan U; Celik B; Ataoğlu O; Biri H; Bozkirli I
    Int Urol Nephrol; 1999; 31(1):75-82. PubMed ID: 10408306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
    Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
    Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
    Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy.
    Noordzij MA; van der Kwast TH; van Steenbrugge GJ; Hop WJ; Schröder FH
    Int J Cancer; 1995 Jul; 62(3):252-8. PubMed ID: 7543077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Zhang ZF; Bazinet M; Hamdy SM; Reuter VE
    J Urol; 1994 Apr; 151(4):914-9. PubMed ID: 8126824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
    Abrahamsson PA; Cockett AT; di Sant'Agnese PA
    Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy.
    Krijnen JL; Bogdanowicz JF; Seldenrijk CA; Mulder PG; van der Kwast TH
    J Urol; 1997 Jul; 158(1):171-4. PubMed ID: 9186347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma.
    Bollito E; Berruti A; Bellina M; Mosca A; Leonardo E; Tarabuzzi R; Cappia S; Ari MM; Tampellini M; Fontana D; Gubetta L; Angeli A; Dogliotti L
    Ann Oncol; 2001; 12 Suppl 2():S159-64. PubMed ID: 11762345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
    Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
    Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer.
    Puccetti L; Supuran CT; Fasolo PP; Conti E; Sebastiani G; Lacquaniti S; Mandras R; Milazzo MG; Dogliani N; De Giuli P; Fasolis G
    Eur Urol; 2005 Aug; 48(2):215-21; Discussion 221-3. PubMed ID: 15992991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples.
    Speights VO; Cohen MK; Riggs MW; Coffield KS; Keegan G; Arber DA
    Br J Urol; 1997 Aug; 80(2):281-6. PubMed ID: 9284203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
    Yu DS; Hsieh DS; Chen HI; Chang SY
    J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
    May M; Siegsmund M; Hammermann F; Loy V; Gunia S
    Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretagogin is a new neuroendocrine marker in the human prostate.
    Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
    Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma.
    McWilliam LJ; Manson C; George NJ
    Br J Urol; 1997 Aug; 80(2):287-90. PubMed ID: 9284204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.